CHARLES COATS: Open Payments
NPI 1700887262 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,579 in 220 payments from 31 companies in 2025. Trend: 2023 $4,356 · 2024 $4,481 · 2025 $7,579
Food & beverage: $4,441Consulting: $3,078Education: $59
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $3,239 |
| AstraZeneca Pharmaceuticals LP | 17 | $702 |
| Madrigal Pharmaceuticals | 26 | $546 |
| Bayer Healthcare Pharmaceuticals Inc. | 26 | $363 |
| ABBVIE INC. | 34 | $278 |
| Vanda Pharmaceuticals Inc. | 14 | $264 |
| Novo Nordisk Inc | 10 | $257 |
| Axsome Therapeutics, Inc. | 11 | $228 |
| Astellas Pharma US Inc | 5 | $227 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $208 |
Products named: REZDIFFRA, AIRSUPRA, Kerendia, BREZTRI, Auvelity, Veozah, JARDIANCE, FANAPT.
Industry payments across IN — which companies pay providers there.
